Phio Pharmaceuticals Financial Overview
Phio Pharmaceuticals's market cap is currently $14.10M. The company's EPS TTM is $-0.44; its P/E ratio is -0.59; Phio Pharmaceuticals is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
